Achieve Life Depreciation And Amortization Over Time

ACHV Stock  USD 4.38  0.03  0.68%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Achieve Life Performance and Achieve Life Correlation.
  
Depreciation And Amortization is likely to climb to about 271.4 K in 2024.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achieve Life. If investors know Achieve will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achieve Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Return On Assets
(0.54)
Return On Equity
(1.86)
The market value of Achieve Life Sciences is measured differently than its book value, which is the value of Achieve that is recorded on the company's balance sheet. Investors also form their own opinion of Achieve Life's value that differs from its market value or its book value, called intrinsic value, which is Achieve Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achieve Life's market value can be influenced by many factors that don't directly affect Achieve Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achieve Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Achieve Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achieve Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Depreciation And Amortization Analysis

Compare Achieve Life Sciences and related stocks such as VectivBio Holding, Icosavax, and Apellis Pharmaceuticals Depreciation And Amortization Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
APLS6.3 K6.3 K6.3 K6.3 K6.6 K53 M11.9 K11.9 K2.9 M5.2 M859 K1.5 M1.5 M1.7 M1.6 M
ITOS505 K505 K505 K505 K505 K505 K505 K505 K505 K6.3 M535 K615 K813 K898 K1.3 M
TCRX519 K519 K519 K519 K519 K519 K519 K519 K519 K519 K1.2 M3.3 M5.1 M5.4 M3.4 M
DAWN(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)(2 K)155 K199 K531 K383 K278.5 K
ABOS147 K147 K147 K147 K147 K147 K147 K147 K147 K147 K7.9 MK169 K184 K174.8 K
XFOR389 K389 K389 K389 K389 K389 K285 K195 K155 K7.8 M351 K1.9 MM419 K398.1 K
INZY26 K26 K26 K26 K26 K26 K26 K26 K26 K83 K217 K1.1 M744 K833 K541.8 K
IMMX1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K1.3 K2.3 K2.5 K2.1 K5.5 KK
CNSP(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)K11.1 K13.1 K11.8 K4.1 K4.3 K
HEPA841 K841 K841 K1.3 K1.3 K16.4 K21.5 K28 K18.8 K26.7 K34.5 K86.1 K77.5 K67.1 K81.3 K
NXTC582 K582 K582 K582 K582 K582 K582 K582 K1.7 M2.7 M3.4 M4.3 M4.1 M3.7 M3.2 M
CTMX655 K655 K655 K655 K783 K1.2 M1.7 M1.6 M1.9 M2.6 M5.5 M2.7 M2.4 M2.2 M2.3 M
SPRO11 K11 K11 K11 K11 K11 K279 K363 K409 K750 K761 K1.1 M1.5 M367 K684.9 K
ASMB4.7 K3.7 K4.6 K6.2 K11 K65 K80.3 K219.2 K643 K494 K691 K466 K498 K450 K251.4 K
BOLT302 K302 K302 K302 K302 K302 K302 K302 K302 K377 K2.5 M3.7 M4.9 M1.9 M2.5 M
CHRS221 K221 K221 K404 K674 K1.9 M22.8 K52.5 K161.1 K171.9 KM5.7 M3.7 M3.8 MM

Achieve Life Sciences and related stocks such as VectivBio Holding, Icosavax, and Apellis Pharmaceuticals Depreciation And Amortization description

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

My Equities

My Current Equities and Potential Positions

Achieve Life Sciences
ACHV
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationWashington; U.S.A
ExchangeNASDAQ Exchange
USD 4.38

Additional Tools for Achieve Stock Analysis

When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.